Skip to content

Application of MR-PET in Colorectal Cancer

Application of MR-PET in Colorectal Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02553031
Enrollment
100
Registered
2015-09-17
Start date
2014-07-31
Completion date
2018-05-31
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Application of MR-PET

Brief summary

This study will explore the potential value in proper therapeutic decision and clinical outcome prediction by using integrated MR-PET system and advanced MR techniques in patients with colorectal cancer.

Detailed description

This research expect that the image techniques and experience in this cancer group may be valuable and helpful for others. With advantage of MR-PET in better soft tissue delineation/functional information and less radiation dose than PET-CT, the ultimate goal in both research and clinical application is to establish new diagnostic standard and management guideline by MR-PET, which can further improve clinical outcome and disease prognosis in patients colorectal cancer.

Interventions

This study will explore the potential value in proper therapeutic decision and clinical outcome prediction by using integrated MR-PET system and advanced MR techniques in patients with colorectal cancer.

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Group 1: Patients with newly diagnosed colorectal cancers 2. Group 2: Patients with suspicious recurrent colorectal cancers

Exclusion criteria

1. Age \<20 or \>90 years old 2. Contraindication for MRI: claustrophobia or MR non-compatible devices 3. Contraindication for MR contrast medium: severe adverse reaction or impaired renal function (Cre \> 2.0) 4. History of other malignancy 5. Prior arthroplasty of hip (may cause artifacts on MRI) 6. Pregnancy

Design outcomes

Primary

MeasureTime frame
The recurrence rate at 1 year after surgery1 year

Secondary

MeasureTime frame
The overall survival at 1 year after surgery1 year

Countries

Taiwan

Contacts

Primary ContactTing-Fang Shih, MD
ttfshih@ntu.edu.tw+886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026